Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia

Leukemia

Volumn 21, Issue 12, 2007, Pages 2470-2475

  Prima, V ^a,b   Hunger, S P ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PROTEIN DAZAP1; PROTEIN MEF2D; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGAR MEDIUM; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN 3T3; CHIMERA; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME TRANSLOCATION; CHROMOSOME VARIANT; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; WILD TYPE;

EID: 36348962959     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404962     Document Type: Article

References (29)

1. Rego EM, Pandolfi PP. Reciprocal products of chromosomal translocations in human cancer pathogenesis: Key players or innocent bystanders? Trends Mol Med 2002; 8: 396-405.
2. Alcalay.M, Zangrilli, D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F et al. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad, Sci USA 1992; 89 4840-4844.
3. Grimwade D, Biondi 4, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M et al. Characterization of acute promyelocytic leukemia cases lackingthe classic t(l5;17): Result of the European Working Party. Blood 2000; 96: 1297-1308.
4. Yuki Y, Imoto I, Imaizumi M; Hibi S, Kaneko Y, Amagasa T et al. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci 2004; 95: 503-507.
5. Prima V, Gore L, Caires A, Boomer T, Yoshinari M, Imaizumi M et al. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia 2005; 19: 806-813.
6. McKinsey TA, Zhang CL, Olson EN. MEF2: A calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 2002; 27: 40-47.
7. Tsui S, Dai T, Roettger S, Schempp W, Salido EC, Yen PH. Identification of two novel proteins that interact with germ-cell-specific RNA-binding proteins DAZ and DAZL1. Genomics 2000; 65: 266-273.
8. Pear W, Scott ML, Nolan GP. Generation of high-titer, helper-free retroviruses by transient transfection. In: Robbins P (ed). Methods in Molecular Medicine: Gene Therapy Protocols. Humana Press: Totowa, NJ, 1996, pp 41-58.
9. Muscat GE, Perry S, Prentice H, Kedes L. The human skeletal alpha-actin gene is regulated by a muscle-specific enhancer that binds three nuclear factors. Gene Expr 1992; 2: 111-126.
10. Qiu RG, Abo A, McCormick F, Symons M. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol Cell Biol 1997; 17: 3449-3458.
11. Moustakas A, Stournaras C. Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts. J Cell Sci 1999; 112 (Part 8): 1169-1179.
12. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 2002; 99: 3780-3785.
13. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
14. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002; 32: 166-174.
15. Sun L, Youn HD, Loh C, Stolow M, He W, Liu JO. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 1998; 8: 703-711.
16. Youn HD, Sun L, Prywes R, Liu JO. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 1999; 286: 790-793.
17. Youn HD, Chatila TA, Liu JO. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J 2000; 19: 4323-4331.
18. Youn HD, Grozinger CM, Liu JO. Calcium regulates, transcriptional repression of myocyte enhincer factor 2 by histone deacetylase 4. J Biol Chem 2000; 275: 22563-22567.
19. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999; 286: 785-790.
20. Shin HH, Seoh JY, Chung HY, Choi SJ; Hahn MJ, Kang JS et al. Requirement of MEF2D in the induced differentiation of HL60 promyeloid cells. Mol Immunol 1999; 36: 1209-1214.
21. Han TH, Prywes R. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol Cell Biol 1995; 15: 2907-2915.
22. Pan F, Ye Z, Cheng L, Liu JO. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: A calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J Biol Chem 2004; 279: 14477-14480.
23. Rao S, Karray S, Gackstetter ER, Koshland ME. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J Biol Chem 1998; 273: 26123-26129.
24. Wallin JJ, Rinkenberger JL, Rao S, Gackstetter ER, Koshland ME, Zwollo P. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J Biol Chem 1999; 274: 15959-15965.
25. Satyaraj E, Storb U. Mef2 proteins, required for muscle differentiation, bind an essential site in the -Ig lambda enhancer. J Immunol 1998; 161: 4795-4802.
26. Morton S, Yang HT, Moleleki N, Campbell DG, Cohen P, Rousseau S. Phosphorylation of the ARE-binding protein DAZAP1 by ERK2 induces its dissociation from DAZ. Biochem J 2006; 399: 265-273.
27. Zhang T, Kruys; V, Huez G, Gueydan C. AU-rich element-mediated translational control: Complexity and multiple activities of transactivating factors. Biochem Soc Trans 2002; 30 (Part 6): 952-958.
28. Perrotti D, Calabretta B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: Role of shuttling RNA-binding proteins. Oncogene 2002; 21: 8577-8583.
29. Ron D. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. Curr Top Microbiol Immunol 1997; 220: 131-142.